Effects of Virtual Reality Hypnosis on Anxiety, Pain and Comfort in Oncology Patients During a Port-catheter Placement Procedure
Launched by UNIVERSITY OF LIEGE · Mar 12, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a new approach called Virtual Reality Hypnosis (VRH) on reducing anxiety and pain in cancer patients who need a procedure to place a port-catheter (PAC). A PAC is a small device implanted in the chest or arm that helps patients receive treatments like chemotherapy more easily. Many patients feel anxious or experience pain during and after this procedure. The trial will involve 102 cancer patients who will be randomly assigned to two groups: one will receive standard care with local anesthesia, while the other will use VRH along with the usual care. Researchers will measure how much pain and anxiety the patients feel before and after the procedure.
To participate in this trial, patients must be between 18 and 75 years old and should not have certain conditions that could interfere with the use of the VR device, such as severe visual or auditory impairments, certain psychiatric disorders, or a fear of deep water. The trial is not yet recruiting participants, but it aims to improve the experience of patients undergoing this common procedure by exploring this innovative method.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Low auditory and/or visual acuity precludes the use of the device.
- • Head or face wounds precluding the use of the device.
- • Schizophrenia, dissociative disorder or any other psychiatric disorder.
- • Non-proficiency in French (Research language).
- • Patient under 18 years old.
- • Phobia of deep water.
- • Dizziness.
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, , Belgium
Huy, Liège, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported